Clinical Trial
doi: 10.5694/j.1326-5377.1979.tb119425.x.
Labetalol and bendrofluazide: comparison of their antihypertensive effects
- PMID: 386062
- DOI: 10.5694/j.1326-5377.1979.tb119425.x
Item in Clipboard
Clinical Trial
Labetalol and bendrofluazide: comparison of their antihypertensive effects
Med J Aust.
.
Abstract
A randomized double-blind crossover trial of labetalol, bendrofluazide and placebo was carried out in 18 patients with mild to moderate hypertension. The reduction in blood pressure observed with labetalol and bendrofluazide was similar. The plasma levels of labetalol showed a significant correlation with changes in blood pressure (r = 0.07; P less than 0.021); and plasma level determinations of this drug may be of value in the management of patients who receive antihypertensive agents.
Similar articles
-
A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.Br J Clin Pharmacol. 1979 Aug;8(2):149-54. doi: 10.1111/j.1365-2125.1979.tb05813.x. Br J Clin Pharmacol. 1979. PMID: 385023 Free PMC article. Clinical Trial.
-
A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.Br J Clin Pharmacol. 1979 Jan;7(1):63-8. doi: 10.1111/j.1365-2125.1979.tb00898.x. Br J Clin Pharmacol. 1979. PMID: 367410 Free PMC article. Clinical Trial.
-
Labetalol and bendrofluazide.Med J Aust. 1979 Oct 6;2(7):366. doi: 10.5694/j.1326-5377.1979.tb104167.x. Med J Aust. 1979. PMID: 514192 No abstract available.
-
Labetalol.Drug Intell Clin Pharm. 1983 Oct;17(10):704-12. Drug Intell Clin Pharm. 1983. PMID: 6354658 Review.
-
[Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].Minerva Cardioangiol. 1981 Dec;29(12):719-28. Minerva Cardioangiol. 1981. PMID: 7038536 Review. Italian. No abstract available.
Cited by
-
Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.Cochrane Database Syst Rev. 2015 Aug 26;2015(8):CD007449. doi: 10.1002/14651858.CD007449.pub2. Cochrane Database Syst Rev. 2015. PMID: 26306578 Free PMC article.
-
Comparison of labetalol with other anti-hypertensive drugs.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):41S-47S. doi: 10.1111/j.1365-2125.1982.tb01888.x. Br J Clin Pharmacol. 1982. PMID: 6124265 Free PMC article. Review.
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005. Drugs. 1984. PMID: 6151891 Review.
-
Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther. 1988 Sep;2(3):343-53. doi: 10.1007/BF00054642. Cardiovasc Drugs Ther. 1988. PMID: 2908732 Review.
-
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.Cochrane Database Syst Rev. 2014 May 29;2014(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Cochrane Database Syst Rev. 2014. PMID: 24869750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
